Comparative Risk of Alzheimer Disease and Related Dementia Among Medicare Beneficiaries With Rheumatoid Arthritis Treated With Targeted Disease-Modifying Antirheumatic Agents-Reference-Cited by-同舟云学术

Comparative Risk of Alzheimer Disease and Related Dementia Among Medicare Beneficiaries With Rheumatoid Arthritis Treated With Targeted Disease-Modifying Antirheumatic Agents

Published:2022-04-08 Issue:4 Volume:5 Page:e226567
ISSN:2574-3805
Container-title:JAMA Network Open
language:en
Short-container-title:JAMA Netw Open

Author:

Desai Rishi J.¹,Varma Vijay R.²,Gerhard Tobias³,Segal Jodi⁴,Mahesri Mufaddal¹,Chin Kristyn¹,Horton Daniel B.³,Kim Seoyoung C.¹⁵,Schneeweiss Sebastian¹,Thambisetty Madhav²

Affiliation:

1. Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts

2. Clinical and Translational Neuroscience Section, Laboratory of Behavioral Neuroscience, National Institute on Aging, Baltimore, Maryland

3. Center for Pharmacoepidemiology and Treatment Science, Ernest Mario School of Pharmacy, Rutgers University, New Brunswick, New Jersey

4. Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland

5. Division of Rheumatology, Inflammation, and Immunity, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2790901/desai_2022_oi_220209_1648733759.94656.pdf

Reference47 articles.

1. Alzheimer’s disease drug-development pipeline: few candidates, frequent failures.;Cummings;Alzheimers Res Ther,2014

2. Reasons for failed trials of disease-modifying treatments for Alzheimer disease and their contribution in recent research.;Yiannopoulou;Biomedicines,2019

3. Alzheimer disease in the United States (2010-2050) estimated using the 2010 census.;Hebert;Neurology,2013

4. Therapeutic strategies for Alzheimer’s disease in clinical trials.;Godyn;Pharmacol Rep,2016

5. Alzheimer disease therapeutics: focus on the disease and not just plaques and tangles.;Iqbal;Biochem Pharmacol,2014

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimising the use of electronic medical records for large scale research in psychiatry;Translational Psychiatry;2024-06-01

2. Inflammation, Autoimmunity and Neurodegenerative Diseases, Therapeutics and Beyond;Current Neuropharmacology;2024-05

3. The RESIST Study: Examining Cognitive Change in Rheumatoid Arthritis Patients with Mild Cognitive Impairment Being Treated with a TNF-Inhibitor Compared to a Conventional Synthetic Disease-Modifying Anti-Rheumatic Drug;Journal of Alzheimer's Disease;2024-04-30

4. JAK1/2 Regulates Synergy Between Interferon Gamma and Lipopolysaccharides in Microglia;Journal of Neuroimmune Pharmacology;2024-04-20

5. Association of Tumor Necrosis Factor-α Inhibitors with Incident Dementia: Analysis Based on Population-Based Cohort Studies;Drugs & Aging;2024-04-12